3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
221
Polycystic Ovary Syndrome
36
Endometrial Neoplasms
15
Ovarian Neoplasms
13
Infertility
11
Neoplasm Metastasis
9
Carcinoma, Intraductal, Noninfiltrating
7
Fallopian Tube Neoplasms
6
Neoplasms
5
Breast Diseases
5
Triple Negative Breast Neoplasms
4
Osteoporosis
4
Leiomyoma
4
Infertility, Female
4
Breast Neoplasms, Male
4
Breast Carcinoma In Situ
4
Arthralgia
4
Advanced Breast Cancer
4
Recurrence
3
Obesity
3
Breast Cancer Metastatic
3
Anovulation
3
Uterine Neoplasms
2
Solid Tumor
2
Prostatic Neoplasms
2
Progesterone Resistance
2
Pancreatic Neoplasms
2
Pain
2
Leiomyosarcoma
2
HR Positive HER2 Negative Advanced Breast Cancer
2
Interventions
Surveys and Questionnaires
3
Blood Specimen Collection
3
Salpingo-oophorectomy
2
Genetic Testing
2
Genetic Counseling
2
Diet, Mediterranean
2
Counseling
2
Videotape Recording
1
Telemedicine
1
Tamoxifen
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Salpingectomy
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Ovariectomy
1
Methods
1
Letrozole
1
Hysterectomy
1
High-Throughput Nucleotide Sequencing
1
Genotype
1
Exercise Test
1
Echocardiography
1
Early Intervention, Educational
1
CA-125 Antigen
1
Buthionine Sulfoximine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Letrozole
×
Clear all
NCT00673335
2024-07-01
LIBER
UNICANCER
Phase 3
Completed
170 enrolled